The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
A “Candidate-Interactome” Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis
Open accessAbstract
Though difficult, the study of gene-environment interactions in multifactorial diseases is crucial for interpreting the relevance of non-heritable factors and prevents from overlooking genetic associations with small but measurable effects. We propose a "candidate interactome" (i.e. a group of genes whose products are known to physically interact with environmental factors that may be relevant for disease pathogenesis) analysis of genome-wide association data in multiple sclerosis. We looked for statistical enrichment of associations among interactomes that, at the current state of knowledge, may be representative of gene-environment interactions of potential, uncertain or unlikely relevance for multiple sclerosis pathogenesis: Epstein-Barr virus, human immunodeficiency virus, hepatitis B virus, hepatitis C virus, cytomegalovirus, HHV8-Kaposi sarcoma, H1N1-influenza, JC virus, human innate immunity interactome for type I interferon, autoimmune regulator, vitamin D receptor, aryl hydrocarbon receptor and a panel of proteins targeted by 70 innate immune-modulating viral open reading frames from 30 viral species. Interactomes were either obtained from the literature or were manually curated. The P values of all single nucleotide polymorphism mapping to a given interactome were obtained from the last genome-wide association study of the International Multiple Sclerosis Genetics Consortium & the Wellcome Trust Case Control Consortium, 2. The interaction between genotype and Epstein Barr virus emerges as relevant for multiple sclerosis etiology. However, in line with recent data on the coexistence of common and unique strategies used by viruses to perturb the human molecular system, also other viruses have a similar potential, though probably less relevant in epidemiological terms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Heritability in the genomics era — concepts and misconceptions
Visscher, P. M., Hill, W. G., & Wray, N. R. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2322 · Cited by 1,921 · cited 1×
“nonheritable factors may help understand their true impact on disease pathogenesis [4].”
BackgroundEnvironmental risk factors for multiple sclerosis. Part I: The role of infection
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21117 · Cited by 1,042
The BioGRID interaction database: 2013 update
Chatr-aryamontri, A., Breitkreutz, B.-J., Heinicke, S., Boucher, L., Winter, A., Stark, C., Nixon, J., Ramage, L., Kolas, N., O’Donnell, L., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1158 · Cited by 1,017
Ramagopalan, S. V., Heger, A., Berlanga, A. J., Maugeri, N. J., Lincoln, M. R., Burrell, A., Handunnetthi, L., Handel, A. E., Disanto, G., Orton, S.-M., et al. (2010) · Genome Research · doi:10.1101/gr.107920.110 · Cited by 873
The BioGRID Interaction Database: 2011 update
Stark, C., Breitkreutz, B.-J., Chatr-aryamontri, A., Boucher, L., Oughtred, R., Livstone, M. S., Nixon, J., Van Auken, K., Wang, X., Shi, X., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1116 · Cited by 854
Global landscape of HIV–human protein complexes
Jäger, S., Cimermancic, P., Gulbahce, N., Johnson, J. R., McGovern, K. E., Clarke, S. C., Shales, M., Mercenne, G., Pache, L., Li, K., et al. (2012) · Nature · doi:10.1038/nature10719 · Cited by 731
A Physical and Regulatory Map of Host-Influenza Interactions Reveals Pathways in H1N1 Infection
Shapira, S. D., Gat-Viks, I., Shum, B. O. V., Dricot, A., de Grace, M. M., Wu, L., Gupta, P. B., Hao, T., Silver, S. J., Root, D. E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.12.018 · Cited by 635
The Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) (2009) · Nature Genetics · doi:10.1038/ng.396 · Cited by 550
Vaccinations and the Risk of Relapse in Multiple Sclerosis
Confavreux, C., Suissa, S., Saddier, P., Bourdès, V., & Vukusic, S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440501 · Cited by 490
Perron, H., Garson, J. A., Bedin, F., Beseme, F., Paranhos-Baccala, G., Komurian-Pradel, F., Mallet, F., Tuke, P. W., Voisset, C., Blond, J. L., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7583 · Cited by 484
Hepatitis B Vaccination and the Risk of Multiple Sclerosis
Ascherio, A., Zhang, S. M., Hernán, M. A., Olek, M. J., Coplan, P. M., Brodovicz, K., & Walker, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440502 · Cited by 433
Epstein–Barr virus and virus human protein interaction maps
Calderwood, M. A., Venkatesan, K., Xing, L., Chase, M. R., Vazquez, A., Holthaus, A. M., Ewence, A. E., Li, N., Hirozane-Kishikawa, T., Hill, D. E., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702332104 · Cited by 388
Hepatitis C virus infection protein network
de Chassey, B., Navratil, V, Tafforeau, L., Hiet, M. S., Aublin‐Gex, A., Agaugué, S., Meiffren, G., Pradezynski, F., Faria, B. F., Chantier, T., et al. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.66 · Cited by 384
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
Gregory, A. P., Dendrou, C. A., Attfield, K. E., Haghikia, A., Xifara, D. K., Butter, F., Poschmann, G., Kaur, G., Lambert, L., Leach, O. A., et al. (2012) · Nature · doi:10.1038/nature11307 · Cited by 384
Pathway and network-based analysis of genome-wide association studies in multiple sclerosis
Baranzini, S. E., Galwey, N. W., Wang, J., Khankhanian, P., Lindberg, R., Pelletier, D., Wu, W., Uitdehaag, B. M. J., Kappos, L., GeneMSA Consortium, et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp120 · Cited by 383
Gene Ontology Analysis of GWA Study Data Sets Provides Insights into the Biology of Bipolar Disorder
Holmans, P., Green, E. K., Pahwa, J. S., Ferreira, M. A. R., Purcell, S. M., Sklar, P., Owen, M. J., O'Donovan, M. C., & Craddock, N. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.05.011 · Cited by 378
The COGENT Consortium, Houlston, R. S., The CORGI Consortium, The COIN Collaborative Group, The COINB Collaborative Group, Cheadle, J., Dobbins, S. E., Tenesa, A., Jones, A. M., Howarth, K., et al. (2010) · Nature Genetics · doi:10.1038/ng.670 · Cited by 360 · cited 6×
“S3) computed by ALIGATOR (Association LIst Go AnnoTatOR) first flow process.”
MethodInfluentialLi, S., Wang, L., Berman, M., Kong, Y.-Y., & Dorf, M. E. (2011) · Immunity · doi:10.1016/j.immuni.2011.06.014 · Cited by 340
Aire's Partners in the Molecular Control of Immunological Tolerance
Abramson, J., Giraud, M., Benoist, C., & Mathis, D. (2010) · Cell · doi:10.1016/j.cell.2009.12.030 · Cited by 328
Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study
Hernán, M. A., Jick, S. S., Olek, M. J., & Jick, H. (2004) · Neurology · doi:10.1212/01.wnl.0000138433.61870.82 · Cited by 304
Ecker, J. R., Bickmore, W. A., Barroso, I., Pritchard, J. K., Gilad, Y., & Segal, E. (2012) · Nature · doi:10.1038/489052a · Cited by 277
Viral immune modulators perturb the human molecular network by common and unique strategies
Pichlmair, A., Kandasamy, K., Alvisi, G., Mulhern, O., Sacco, R., Habjan, M., Binder, M., Stefanovic, A., Eberle, C.-A., Goncalves, A., et al. (2012) · Nature · doi:10.1038/nature11289 · Cited by 262
Rare variants in the CYP27B1 gene are associated with multiple sclerosis
Ramagopalan, S. V., Dyment, D. A., Cader, M. Z., Morrison, K. M., Disanto, G., Morahan, J. M., Berlanga‐Taylor, A. J., Handel, A., De Luca, G. C., Sadovnick, A. D., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22678 · Cited by 229
Perron, H., Germi, R., Bernard, C., Garcia-Montojo, M., Deluen, C., Farinelli, L., Faucard, R., Veas, F., Stefas, I., Fabriek, B. O., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512441381 · Cited by 208
Environmental risk factors for multiple sclerosis
Salzer, J. (2013) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 202
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood
Mikaeloff, Y., Caridade, G., Suissa, S., & Tardieu, M. (2008) · Neurology · doi:10.1212/01.wnl.0000335762.42177.07 · Cited by 148
The virology of demyelinating diseases
Johnson, R. T. (1994) · Annals of Neurology · doi:10.1002/ana.410360715 · Cited by 145
Orozco, L. D., Bennett, B. J., Farber, C. R., Ghazalpour, A., Pan, C., Che, N., Wen, P.-Z., Qi, H. X., Mutukulu, A., Siemers, N. O., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.043 · Cited by 145
Viral Perturbations of Host Networks Reflect Disease Etiology
Gulbahce, N., Yan, H., Dricot, A., Padi, M., Byrdsong, D., Franchi, R., Lee, D., Rozenblatt–Rosen, O., Mar, J. C., Calderwood, M. A., et al. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002531 · Cited by 114
Vaccination against infection in patients with multiple sclerosis
Loebermann, M., Winkelmann, A., Hartung, H., Hengel, H., Reisinger, E. C., & Zettl, U. K. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.8 · Cited by 102
Envelope Gene of the Human Endogenous Retrovirus HERV-W Encodes a Functional Retrovirus Envelope
An, D. S., Xie, Y., & Chen, I. S. Y. (2001) · Journal of Virology · doi:10.1128/jvi.75.7.3488-3489.2001 · Cited by 85
Environmental triggers of multiple sclerosis
Kakalacheva, K., & Lünemann, J. D. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.006 · Cited by 83
Vitamin D receptor binding, chromatin states and association with multiple sclerosis
Disanto, G., Sandve, G. K., Berlanga‐Taylor, A. J., Ragnedda, G., Morahan, J. M., Watson, C. T., Giovannoni, G., Ebers, G. C., & Ramagopalan, S. V. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds189 · Cited by 53
What is a gene? An updated operational definition
Pesole, G. (2008) · Gene · doi:10.1016/j.gene.2008.03.010 · Cited by 51
Stajich, J. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-535-0_26 · Cited by 46
A database and API for variation, dense genotyping and resequencing data
Ríos, D., McLaren, W. M., Chen, Y., Birney, E., Stabenau, A., Flicek, P., & Cunningham, F. M. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-238 · Cited by 43
Risk in complex genetics: “All models are wrong but some are useful”
Sawcer, S. J., & Wason, J. M. S. (2012) · Annals of Neurology · doi:10.1002/ana.23613 · Cited by 13
Cited by
BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes
Jespersen, M. C., Peters, B., Nielsen, M., & Marcatili, P. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx346 · Cited by 1,746
Shafey, A. M. E. (2020) · Green Processing and Synthesis · doi:10.1515/gps-2020-0031 · Cited by 838
Are Structural Analogues to Bisphenol A Safe Alternatives?
Rosenmai, A. K., Dybdahl, M., Pedersen, M., Alice van Vugt-Lussenburg, B. M., Wedebye, E. B., Taxvig, C., & Vinggaard, A. M. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu030 · Cited by 428
Eliot, L., Ahmed, A., Khan, H., & Patel, J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.026 · Cited by 360
Norm antipreneurs and theorising resistance to normative change
BLOOMFIELD, A. (2016) · Review of International Studies · doi:10.1017/s026021051500025x · Cited by 311
Metadata
- Authors
- Mechelli, R., Umeton, R., Policano, C., Annibali, V., Coarelli, G., Ricigliano, V. A. G., Vittori, D., Fornasiero, A., Buscarinu, M. C., International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium, 2., Romano, S., Salvetti, M., & Ristori, G.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-05-16
- Volume
- 8
- Issue
- 5
- Pages
- e63300
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2038266768
- Cited by
- 509
- References
- 38
- FWCI
- 42.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.